Insider Trading Stories

Purchase by H Birzer of 100 shares of Tortoise Power

 6 hours ago at MacroaxisInsider 
Filed By H Birzer, Tortoise Power And
Filed transaction by Tortoise Power Energy Inf director. General open market or private purchase of non-derivative or derivative security. Tortoise insider trading alert for perchase of common shares by H Birzer, the corporate stakeholder, on 25th of January 2022. This event was filed by Tortoise Power Energy Inf with SEC on 2022-01-25. Statement of changes in beneficial ownership - SEC Form 4. H Birzer currently serves as chairman of the board of director of Tortoise Power And [more]
null Tortoise power
Pulmonx Corp
  few hours ago at Macroaxis
Filed for French Glendon E Iii
Filed transaction by Pulmonx Corp director. General open market or private sale of non-derivative or derivative security. Pulmonx insider trading alert for sale of common stock by French Glendon E Iii, President and CEO, on 24th of January 2022. This event was filed by Pulmonx Corp with SEC on 2022-01-24. Statement of changes in beneficial ownership - SEC Form 4  
Virios Therapeutics
  few hours ago at Macroaxis
Filed for De La Rosa Abel
Filed transaction by Virios Therapeutics Inc director. General open market or private purchase of non-derivative or derivative security. Virios insider trading alert for perchase of common stock by De La Rosa Abel, the corporate stakeholder, on 7th of January 2022. This event was filed by Virios Therapeutics Inc with SEC on 2022-01-07. Statement of changes in beneficial ownership - SEC Form 4  
LENSAR Inc
  few hours ago at Macroaxis
Filed for Wong Kendra
Filed transaction by Lensar Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d). LENSAR insider trading alert for grant of stock option (right to buy) by Wong Kendra, Principal Accounting Officer, on 13th of January 2022. This event was filed by Lensar Inc with SEC on 2022-01-13. Statement of changes in beneficial ownership - SEC Form 4  
Iota Communications
  few hours ago at Macroaxis
Filed for Dullinger James Francis
Filed transaction by Iota Communications Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d). Iota Communications insider trading alert for grant of stock options (right to buy) by Dullinger James Francis, Chief Financial Officer, on 7th of January 2022. This event was filed by Iota Communications Inc with SEC on 2022-01-07. Statement of changes in beneficial ownership - SEC Form 4  
Optex Systems Hlds
  few hours ago at Macroaxis
Filed for Danny Schoening
Filed transaction by Optex Systems Holdings In director. Grant, award or other acquisition pursuant to Rule 16b-3(d). Optex insider trading alert for grant of common stock by Danny Schoening, PRESIDENT & CEO, on 24th of January 2022. This event was filed by Optex Systems Holdings In with SEC on 2022-01-24. Statement of changes in beneficial ownership - SEC Form 4. Danny Schoening currently serves as ceo, coo, general manager and director of Optex Systems Hlds  
Synalloy Cp
  3 hours ago at Macroaxis
Filed for Tackett Glenn Douglas Jr
Filed transaction by Synalloy Corp officer. Payment of exercise price or tax liability by delivering or withholding securities. Synalloy insider trading alert for payment of common stock by Tackett Glenn Douglas Jr, Chief Legal Officer, on 7th of January 2022. This event was filed by Synalloy Corp with SEC on 2022-01-07. Statement of changes in beneficial ownership - SEC Form 4  
Cls Holdings USA
  3 hours ago at Macroaxis
Filed for Navy Capital Green Management Llc
Filed transaction by Cls Holdings Usa Inc executive. General open market or private purchase of non-derivative or derivative security. Cls Holdings insider trading alert for perchase of warrants by Navy Capital Green Management Llc, the corporate stakeholder, on 7th of January 2022. This event was filed by Cls Holdings Usa Inc with SEC on 2022-01-07. Statement of changes in beneficial ownership - SEC Form 4  
Nurix Therapeutics
  4 hours ago at Macroaxis
Filed for Van Houte Hans
Filed transaction by Nurix Therapeutics Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d). Nurix insider trading alert for grant of restricted stock units by Van Houte Hans, Chief Financial Officer, on 21st of January 2022. This event was filed by Nurix Therapeutics Inc with SEC on 2022-01-21. Statement of changes in beneficial ownership - SEC Form 4  
Nurix Therapeutics
  4 hours ago at Macroaxis
Filed for Ring Christine
Filed transaction by Nurix Therapeutics Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3. Nurix insider trading alert for exercise of employee stock option (right to buy) by Ring Christine, General Counsel, on 11th of January 2022. This event was filed by Nurix Therapeutics Inc with SEC on 2022-01-11. Statement of changes in beneficial ownership - SEC Form 4